Without calcifications in the tumor contributed to a HER2-zero outcome, and a smaller tumor size contributed to HER2-zero and HER2-low outcomes, whereas a larger tumor size and calcifications contributed to a high probability of HER2-positive. The gene discussed is ERBB2; the disease is neoplasm.